P-selectin/ PSGL-1 Inhibitors versus enoxaparin in the resolution of venous thrombosis: A meta-analysis
- 30 April 2010
- journal article
- research article
- Published by Elsevier BV in Thrombosis Research
- Vol. 125 (4), e138-e142
- https://doi.org/10.1016/j.thromres.2009.10.022
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolismThrombosis and Haemostasis, 2008
- Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulationThrombosis and Haemostasis, 2008
- High Concentrations of Soluble P-Selectin Are Associated with Risk of Venous Thromboembolism and the P-Selectin Thr715 VariantClinical Chemistry, 2007
- Effect of P-Selectin on Phosphatidylserine Exposure and Surface-Dependent Thrombin Generation on MonocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Role of P-selectin and PSGL-1 in coagulation and thrombosisThrombosis and Haemostasis, 2004
- Increased soluble P‐selectin levels following deep venous thrombosis: cause or effect?British Journal of Haematology, 2000
- Long-term outcomes after deep venous thrombosis of the lower extremitiesVascular Medicine, 1998
- Low-Molecular-Weight HeparinsThe New England Journal of Medicine, 1997
- Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosisJournal of Vascular Surgery, 1997
- Neutrophils and Deep Venous ThrombosisPathophysiology of Haemostasis and Thrombosis, 1993